Combination of Talimogene Laherparepvec with Atezolizumab in patients with residual breast cancer after standard neoadjuvant multi-agent chemotherapy
Aleix Prat, MD, PhD (Hospital Clínic de Barcelona)
Tomás Pascual, MD(Hospital Clínic de Barcelona)